25 - 28 May 2013, Lisbon - Portugal

Session Details

Late breaking trials 1
Sun 26 May 11:00 - 12:30 Miscellaneous Special Session, Latest Updates Lisboa - Lecture rooms
Chairpersons: John MCMURRAY (Glasgow, GB), Stefan ANKER (Berlin, DE)
Learning Objectives: Latest updates This session will feature the latest breakthrough in clinical heart failure research. Consult session details in the Congress News, on your Mobile Application or on the Website! Trial Presentations of 10 minutes followed by a discussant review and questions from the audience and chairpersons for 3 minutes.

Abstract Slides/e-posters Video Report

List of Presentations

Related documents
11:0091Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial.Gerasimos FILIPPATOS (Athens, GR)
11:1092Discussion: RELAX-AHF.Mihai GHEORGHIADE (Chicago, US)
11:1593Effectiveness and safety of continuous infusion compared to intermittent boluses of intravenous furosemide in acutely decompensated heart failure: a randomized clinical trial.Oscar MIRO (Barcelona, ES)
11:2594Discussion: Diuretic regimens in ADHF. G Michael FELKER (Durham, US)
11:3095Prospective study of the Revivent Myocardial Anchoring System for Less Invasive Treatment of Ischemic Cardiomyopathy (CONFIGURE HF), Phase I John R TEERLINK (San Francisco, US)
11:4096Discussion: CONFIGURE-HF. Marco METRA (Brescia, IT)
11:4597Galectin-3 Reflects Functional Capacity and Clinical Outcome in Heart Failure with Preserved Ejection FractionFrank EDELMANN (Goettingen, DE)
11:5598Discussion: ALDO-DHF BMs.Bertram PITT (Ann Arbor, US)
12:0099The Vildagliptin in Ventricular Dysfunction Diabetes trial (VIVIDD).John MCMURRAY (Glasgow, GB)
12:10100Discussion: VIVIDD.Wolfram DOEHNER (Berlin, DE)
12:15101A randomized, double-blind, placebo-controlled, multicentric study to assess hemodynamic effects of serelaxin in acute heart failure patients.Piotr PONIKOWSKI (Wroclaw, PL)
12:25102Discussion: Serelaxin – Haemodynamics.Alexandre MEBAZAA (Paris, FR)